Human Papillomavirus: Clinical Trials

5 trials for Human Papillomavirus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5
Phase 11Completed 1

Follow Human Papillomavirus: new trials by email Literature Review of Human Papillomavirus trials Research Report on Human Papillomavirus

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya
Artesunate vaginal inserts, Placebo vaginal inserts - Human Immunodeficiency Virus, Human Papillomavirus
Phase 2CompletedUNC Lineberger Comprehensive Cancer Center1202025-01-222026-05-14
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
Bintrafusp Alfa, PDS01ADC, Entinostat - Oropharyngeal Cancer, Neck Cancer
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)552021-10-052026-09-22
Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females
HPV-16/18 vaccine - Human Papillomavirus, Cervical Intraepithelial Neoplasia
Phase 2CompletedShanghai Zerun Biotechnology Co.,Ltd9002016-02-012023-04-13
Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females
HPV vaccine, Placebo - Human Papillomavirus
Phase 2CompletedShanghai Zerun Biotechnology Co.,Ltd12002013-09-012023-04-13
Study of Gardasil in Mid-Adult Males (MAM)
Gardasil - Human Papillomavirus
Phase 2CompletedH. Lee Moffitt Cancer Center and Research Institute1502013-02-192021-09-16

Narrower conditions

Uterine Cervical Dysplasia (2)  ·  Uterine Cervical Neoplasms (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Anus Neoplasms (1)  ·  Colonic Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Oropharyngeal Neoplasms (1)  ·  Penile Neoplasms (1)  ·  Persistent Infection (1)  ·  Vaginal Neoplasms (1)  ·  Vulvar Neoplasms (1)

Broader conditions

Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Genital Diseases (4)  ·  Genital Diseases, Female (4)  ·  Neoplasms (4)  ·  Urogenital Diseases (4)  ·  Uterine Cervical Diseases (4)  ·  Uterine Diseases (4)  ·  Genital Neoplasms, Female (2)  ·  Infections (2)  ·  Neoplasms by Site (2)  ·  Precancerous Conditions (2)  ·  Urogenital Neoplasms (2)  ·  Uterine Neoplasms (2)  ·  Anus Diseases (1)

Interventions

Papillomavirus Vaccines (2)  ·  Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1)  ·  bintrafusp alfa protein, human (1)  ·  entinostat (1)

Sponsors

Shanghai Zerun Biotechnology Co.,Ltd (2)  ·  H. Lee Moffitt Cancer Center and Research Institute (1)  ·  National Cancer Institute (NCI) (1)  ·  UNC Lineberger Comprehensive Cancer Center (1)

Countries

China (2)  ·  United States (2)  ·  Kenya (1)  ·  Mexico (1)

Top investigators

Anna Giuliano, Ph.D. (1)  ·  Chemtai Mungo, MD, MPH (1)  ·  Hoyoung M Maeng, M.D. (1)  ·  Rong-cheng Li, MD (1)  ·  Zhaojun Mo (1)

Results publications

PMID 40907021

NIH funding

R34CA284983 (1)